PT 141 (Bremelanotide)
10mgPT 141 is a peptide developed by Palatin Technologies that acts as an agonist of the melanocortin receptor MC1, used for treating various sexual dysfunctions and other health problems. Bremelanotide is the synthetic analog of melanocyte-stimulating hormone (α-MSH), which stimulates melanin production in the skin. PT141 was created as a medication for sexual dysfunction and is applied to other medical problems. PT 141 acts as a stimulant of melanocyte receptors and xanthine receptors. This helps increase libido and sexual desire in men and women. This peptide helps improve erectile function in men and assists in treating various types of sexual dysfunction in women. Research continues on Bremelanotide PT 141 for its positive influence on problems with depression, mental health, chronic pain, hormonal imbalance, and other health issues.
Key Benefits
- Improves libido and increases sexual desire in men and women.
- Improves erectile function in men and helps improve blood circulation in genital organs.
- Improves sexual sensations and increases achievement of more pleasant orgasm.
- Does not affect mental health and does not cause euphoria feeling.
- Used in treating various sexual dysfunctions in women and men as an alternative to other products.
- Leads to improved self-confidence and assurance during sexual contact.
- Does not cause any adverse effects on the body and psyche of the user.
- Beneficial for female sexual dysfunction, improving experience and sexual desire.
- Positively influences post-traumatic stress disorder by reducing feelings of fear, anxiety, and worry.
- Has rapid action with effects observed within hours.
Clinical Research
PT 141 has been researched in the field of supporting sexual function in men and women. Multiple clinical trials prove its positive effect for treating sexual dysfunctions. In a clinical trial conducted in 2000 by Dr. Hula Clodel, women suffering from hyposexual disorder participated. Participants were divided into two groups, with the first group treated with PT 141 and the second with placebo. Results showed that women taking peptide PT 141 observed higher levels of sexual desire and higher satisfaction from sexual activity. In 2004, another clinical study was conducted involving 21 men suffering from erectile dysfunction. Application of PT 141 showed significantly higher levels of sexual stimulation, longer-lasting erections, and overall improvement in sexual function. In 2010, a third study on PT141's influence was conducted, published in the Journal of Sexual Medicine. This study involved 327 women suffering from hyposexual disorder. Application of PT-141 on participants established improvement in sexual satisfaction, desire, and activity.
Usage & Dosage
- Dosage of peptide PT141 can vary depending on individual needs.
- Typically initial dose in studies is from 400mcg to 700mcg PT 141.
- Expected effect from 1 to 6 hours.
- Administration scheme: 8 units subcutaneously up to 7 hours before sexual contact if possible in the evening and another 5 units in the morning.
- Expected effect: in the following 30 hours.
- Second administration scheme: 10-12 units several hours before sexual contact.
- One pen contains 200 units of 50 micrograms each.
Possible Side Effects
PT-141 has been widely studied for its effects on sexual function. As with any peptide, some users may experience mild side effects.
Potential side effects include:
- Headache
- Nausea
- Skin irritation
- Elevated blood pressure
These reactions are generally short-lived and tend to resolve within a few days. If symptoms persist or become bothersome, professional guidance is recommended.
Proper Storage
It is recommended that the products are stored at temperatures between 2°C and 8°C in a refrigerator.
Disclaimer
This content is provided for informational purposes only and does not constitute medical advice. The products referenced here are intended strictly for laboratory, scientific, and research use. Always consult a qualified healthcare professional before considering any use or application of these products.